Vermilion Energy Inc (VET.TO)

Likes the dividend. One acquisition brought their international exposure down, which hurt. Pretty good management. Still have high net backs and low cap requirements. Dividend is safe, and will keep going up. Eventually, people will start loving oil stocks again, so the risk/reward is good. Yield is 6.7%. (Analysts’ price target is $56.77.)

It has a lot of its oil and gas play in Europe to get international prices. It is not the same as a typical Canadian oil and gas play. He likes it right here. It has a decent yield.

One of the only companies in the energy space that did not cut its distributions during the downturn. An international company where most of the earnings are outside Canada. Their strong balance sheet allowed them to make a great acquisition recently, basically for a stock swap. This will allow them to benefit from growth in Canada, when it returns, but have the diversification of international holdings. Yield 6.9%. (Analysts’ price target is $56.77)

It's been beaten up with all oil stocks. It's irrational that investors are piling into tech and ignoring energy. This is an excellent company with global assets. Cheap here.

Dividend quality very strong. Linked to oil prices. Very strong balance sheet and very low payout ratio. Can get dividends and some growth for the next 2 years. Yield is 6.6%. (Analysts’ price target is $56.88.)

Altagas versus Vermillion. VET-T is oil with some exposure into France and a little expensive. ALA-T has been beat down on the recent acquisition in Washington. Depending on your outlook on energy, ALA-T will act more defensively. But if you believe in $100 WTI, then he would go with VET-T.

This is a Canadian energy stock but, unlike many others, its operations are international, with operations in Europe and other countries. This makes it more attractive. They made an acquisition, of Spartan, at a very good price but the stock is down anyway because it increases their Canadian exposure. He sees this as an opportunity. (Analysts’ price target is $57.00)

It''s been testing lows lately and been choppy the whole year. It's positve that we're now in the low-$40's. A pop in the US dollar will increase this. Ride this out until the whole energy sector sees a resolution.

VET-T vs. SU-T vs. CNQ–T. CNQ-T is the cheapest of the three in terms of price to book. It has a nice upside potential of 40% on current earnings, which have been rising at a nice clip. Buy the cheapest of the three.

He likes these guys. They have a lot of international exposure. Well run operator. 27% production growth. Balance sheet is getting better. 6% dividend yield with an 80% payout ratio. The only problem is that it is expensive relative to its peers. If you believe oil will continue to hold or go up this is a great name to own.

Hold it if you own it. The dividend is very attractive. Management has done a fabulous job. In the low $40s it would make a lot of sense. The balance sheet is improving a lot from their current deal. The company has a lot of legs. It would be a strong buy in the low $40s.

(A Top Pick June 27/17 Up 20%) They did not overpay for the acquisition of Spartan and oil prices have increased substantially. This is a core position in their portfolio. The yield is very attractive. He continues to recommend it. Yield 5%

International exposure that kind of shield you from the pipelines problems in Canada. Dividend of 6%. Cash flows growing. Safe-ish 80% payout ratio. Good balance sheet. The thing that isn’t perfect is that they trade at a small premium o its peers. As long you believe in oil this is a buy.

It bought Spartan and people thought it was a fabulous acquisition. It took the debt up but the equity went up even more. It now has a decent balance sheet. Lower, it would be a fabulous buy.

Has held up well compared to peers. You have Brent exposure. He thinks the differential between Brent and WTI will continue to widen from here. You have a management team people like and a good balance sheet. He thinks he can do better than this, though. It is a solid name.